Using a defined cardiogenic shock best practices protocol derived from real-world data for cardiogenic shock treatment has been associated with improved outcomes. Download this cardiogenic shock guidelines pocket guide, offering best practices derived from the Abiomed Impella® Quality (IQ) Assurance Program and IRB-approved cVAD Study including, minimizing exposure to toxic inotropic medicines, unloading the left … Continue reading “Cardiogenic Shock Protocol Pocket Guide”
A preponderance of evidence from the FDA cVAD Study, Impella Quality Assurance Database and physician-initiated National Cardiogenic Shock Initiative support the recommendation that placing Impella 2.5 or Impella CP pre-PCI improves outcomes.
Use this FDA-approved checklist to guide treatment decisions and determine if the Impella RP is right for your patients. IMP-574
By Dr. Cathy Jeon, Abiomed Medical Director
Successfully treating cardiogenic shock requires getting a multi-disciplinary team to quickly agree on the patient’s condition and treatment protocol.That’s why more cardiogenic shock units are adapting treatment algorithms to help quickly guide decision-making and ensure the best possible outcomes for patients. In a video roundtable hosted by Abiomed focused on “Adopting a Protocol for Cardiogenic Shock,” we spoke with two physicians who have developed algorithms at their own institutions about the benefits they provide and how to maximize their effectiveness.The treatment of cardiogenic shock has changed dramatically in recent years. Tools like vasopressors and inotropes, PCI, mechanical circulatory support, and durable support devices have begun to reduce the mortality of what was once a highly fatal condition. With prompt delivery of appropriate interventions, many more patients who reach the hospital in cardiogenic shock can be treated successfully.In addition, successfully treating cardiogenic shock requires the coordination of emergency medical personnel, emergency department physicians, interventionalists, and intensive care cardiologists, according to a 2016 paper
by Dr. Jacob Doll of Duke University Medical Center and colleagues.So the challenge today is how to work together as a team to identify cardiogenic shock in the setting of an evolving myocardial infarction and to choose treatment in addition to the routine PCI to revascularize the patient."Developing an algorithm to optimize treatment can help us meet that challenge," said Dr. Jon George, director of the cardiac catheterization laboratory at Einstein Medical Center in Philadelphia.“In shock decisions need to be made rapidly and quickly under a lot of stress with a lot of people around you, and these decisions can vary between providers based on anecdotal evidence or experience. So a protocol will standardize the approach for optimal outcomes based on a validated treatment pathway,” Dr. George said.Continue readingAdopting a Protocol for Cardiogenic Shock – Pitfalls and Pathways to Success